knowledge -WSS

knowledge

author：entertainment 2025-09-27 17:10:19 Page View：8828

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

Sponsored By

Previous article： Weighted lottery helped low
Next article： Guidelines to prevent youth baseball injuries need more muscle

explore

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

A rare thyroid diagnosis led to unexpected, all

Photoillustration:CaseySheneryforSTATAnnieLarsson,40,isnostrangertochronicconditions.Shewasdiagnosed

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

TheFDAisrampingupitseffortstoforcevapeshopsandotherretailerstostopsellingElfBarandEscoBarproducts.PA